This test expands Roche's early diagnostics portfolio by screening for Spinal Muscular Atrophy (SMA), Severe Combined ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...
My sexual partner told me later that they had chlamydia.”“My partner had syphilis. I’m worried that I might be infected ...
USA: The cooling tower at the Yankee Stadium in New York’s South Bronx is one of 10 ordered to be treated following a ...
Impara a leggere le etichette green: standard, LCA e indicatori misurabili per distinguere marketing e dati. Domande chiave ...
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today. From reproductive rights to climate change to Big Tech, The Independent is on ...
The global in vitro diagnostics market is projected to grow from USD 117.39 billion in 2026 to USD 170.10 billion by 2031, ...
Animal health officials say sample-processing bottlenecks, not lack of laboratory capacity, caused the bluetongue testing ...
Sleep Cycle announced the results of its research collaboration with the UK Health Security Agency (UKHSA). The joint study evaluated whether aggregated, nightly cough data collected privacy-preserved ...
Stockhead on MSN
Scott Power: Week of wins and setbacks for ASX healthcare sector
It was a mixed week for ASX healthcare, with Paradigm stumbling in phase III, Telix striking a $3.3bn deal and ... Read More ...
The global lateral flow assay market is projected to grow from USD 11.04 billion in 2026 to USD 16.37 billion by 2031, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results